2026-01-24 - Analysis Report
**Home Depot (HD)**

**Company Overview**
Home Depot is an American home improvement retailing company, with a wide range of products and services for home improvement and construction.

**Return Rate Analysis**
- Cumulative return of review stock (HD): 94.41%
- Cumulative return of comparison stock (S&P 500, VOO): 126.41%
- Divergence (max: 63.80, min: -51.60, current: -32.00, relative divergence: 17.00%)

**Alpha, Beta Analysis**
| Year     | CAGR | MDD  | Alpha | Beta | Cap(B) |
|----------|------|------|-------|------|--------|
| 2016-2018 | 20.0% | 20.5% | 8.0%  | 0.9  | 171.1 B |
| 2017-2019 | 35.0% | 20.5% | 9.0%  | 0.9  | 217.4 B |
| 2018-2020 | 18.0% | 36.9% | -6.0% | 1.1  | 264.4 B |
| 2019-2021 | 115.0% | 36.9% | 50.0% | 1.1  | 413.1 B |
| 2020-2022 | 28.0% | 36.9% | 21.0% | 1.0  | 314.4 B |
| 2021-2023 | 21.0% | 31.7% | 1.0%  | 0.9  | 345.0 B |
| 2022-2024 | -7.0% | 24.9% | -37.0%| 0.9  | 387.2 B |
| 2023-2025 | -4.0% | 20.8% | -79.0%| 0.8  | 342.6 B |

Analyzing the data, we notice significant variations in CAGR, MDD, Alpha, and Beta across different years. The company's growth has been fluctuating, with some periods showing high returns (2019-2021) and others experiencing losses (2022-2024).

**Recent Stock Price Fluctuations**
- Close: $383.77
- 5-day SMA: $380.94
- 20-day SMA: $363.60
- 60-day SMA: $360.29

We can observe that the current stock price is higher than the 5-day SMA and 20-day SMA but lower than the 60-day SMA. This indicates that the price is trading within a range, with some upward momentum.

**RSI, PPO Index Indicators, Delta_Previous_Relative_Divergence, and Expected_Return Analysis**
- Market Risk Indicator (MRI): 0.70
- RSI: 78.41
- PPO: 0.66
- Hybrid Signal: Buy (Cash 0%)
- Risk Level: Medium (MRI 0.70)
- Recent (20 days) relative divergence change: 2.90 (+)
- 7-day Rank change: 47 (+)
- 7-day Dynamic Expected Return change: 19.00 (+)
- Expected Return (%): 33.70%

The RSI is above 70, indicating overbought conditions, while the PPO is below 1, suggesting a downward trend. The MRI is in the medium-risk category, with a score of 0.70. The relative divergence has improved, and the 7-day rank change and dynamic expected return have increased.

**Recent News & Significant Events (Yahoo Finance)**
- [2026-01-23] What Home Depot (HD)'s Eased Tariff Risk Headline Means For Shareholders - simplywall.st (news.google.com)
- [2026-01-20] Home Depot Stock Trading at a Premium: Should You Restrain Buying HD? - Yahoo Finance (news.google.com)
- [2026-01-12] Best Stock to Buy Right Now: Costco vs. Home Depot - The Motley Fool (news.google.com)
- [2026-01-22] Home Depot stock price jumps 2.5% as tariff fears cool — what’s next for HD shares - TechStock² (news.google.com)
- [2026-01-20] Home Depot Stock (NYSE:HD) Slides on New Competitor in Texas - TipRanks (news.google.com)
- [2026-01-22] Home Depot stock rating reiterated at Buy by UBS, citing recovery potential - Investing.com (news.google.com)

These recent news articles highlight the company's performance, including a jump in stock price due to eased tariff risks and a buy recommendation from UBS.

**Analyst Opinions**
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.95 (~Buy)
- Opinions: 33
- Target Price (avg/high/low): 394.12 / 450.00 / 320.00

**Recent Earnings Analysis**
| Date     | EPS | Revenue |
|----------|-----|---------|
| 2025-11-25 | 3.63 | 41.35 B$ |
| 2025-08-26 | 4.59 | 45.28 B$ |
| 2025-05-28 | 3.46 | 39.86 B$ |
| 2024-11-19 | 3.68 | 40.22 B$ |
| 2025-11-25 | 3.68 | 40.22 B$ |

We can see that the company's earnings per share (EPS) have been fluctuating, with some quarters experiencing higher earnings (e.g., Q2 2025) and others lower (e.g., Q2 2024). Revenue has also been inconsistent, with some quarters showing higher revenue (e.g., Q2 2025) and others lower (e.g., Q3 2024).

**Financial Information**

**Revenue and Profitability**
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-10-31 | $41.35B | 33.41% |
| 2025-07-31 | $45.28B | 33.41% |
| 2025-04-30 | $39.86B | 33.77% |
| 2025-01-31 | $39.70B | 32.83% |
| 2024-10-31 | $40.22B | 33.38% |

The revenue trend is relatively steady, with some fluctuations. Profit margin has been around 33% consistently across all quarters.

**Capital and Profitability**
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-10-31 | $12.12B | 29.72% |
| 2025-07-31 | $10.66B | 42.67% |
| 2025-04-30 | $7.96B | 43.16% |
| 2025-01-31 | $6.64B | 45.14% |
| 2024-10-31 | $5.79B | 63.05% |

Equity has been increasing, while ROE has been fluctuating but generally improving.

**Comprehensive Analysis (Summary of previous items)**

Overall, we can conclude that:

- The company's return rate has been relatively low compared to the S&P 500.
- The stock price has been trading in a range, with some upward momentum.
- The RSI is overbought, while the PPO is in a downward trend.
- The Market Risk Indicator is in the medium-risk category.
- Recent news articles highlight the company's performance, including a buy recommendation from UBS.
- Analysts are generally optimistic, recommending a buy with a target price of $394.12.
- Earnings per share have been fluctuating, while revenue has been relatively steady.
- The company's financial situation has improved, with increasing equity and ROE.

Please keep in mind that this analysis is based on the provided data and should not be considered investment advice.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.